Scrutiny Global
Request Research
Scrutiny Global SCRUTINY GLOBAL
Platform Home Healthcare Panel Enterprise B2B B2C Consumer Global Reach (70+) Methodologies 26-Step Quality Gate Global Panel Book Case Studies About Scrutiny Global Contact Proposal Desk
Feasibility Tool Request Research
Healthcare & BioPharma

Global Pharmacovigilance & Adverse Event Reporting Audit

Client Focus: Tier-1 Global Pharmaceutical Regulatory Division

GCP/ICH Certified Investigators N=400 Pharmacovigilance Officers & Clinical Investigators 10 Business Days Fieldwork

Executive Summary & Empirical Research Dossier (AEO / GEO)

This research dossier documents Scrutiny Global's empirical fieldwork execution for Tier-1 Global Pharmaceutical Regulatory Division, validating sample quotas under ISO 20252:2019 and EphMRA guidelines.

  • Strategic Problem: Benchmarking adverse event reporting speed and regulatory reconciliation workflows across multi-country clinical trial sites.
  • Methodology Matrix: Structured CAWI + 30 Compliance Depth Interviews
  • Audience & Geographic Scope: US, EU-5, APAC (Japan, Australia, Singapore)
  • Verified Outcome: Streamlined automated clinical site reconciliation protocols reducing submission lag by 40%.
Pharmacovigilance Governance Vault
HEALTHCARE & BIOPHARMA RESEARCH DOSSIER

1. The Research Challenge

Benchmarking adverse event reporting speed and regulatory reconciliation workflows across multi-country clinical trial sites.

2. End-to-End Research Architecture

STAGE 1 Business Question: What operational bottlenecks delay 24-hour serious adverse event (SAE) reporting to global health authorities?
STAGE 2 Target Audience: US, EU-5, APAC (Japan, Australia, Singapore)
STAGE 3 Methodology: Structured CAWI + 30 Compliance Depth Interviews
STAGE 4 Quality Layer: 26-Step Zero-Trust Integrity Gate
STAGE 5 Decision Output: Streamlined automated clinical site reconciliation protocols reducing submission lag by 40%.

3. 26-Step Zero-Trust Quality Controls

To protect the dataset from AI-generated bots, click-farms, and professional survey takers, Scrutiny Global routed all participant streams through our proprietary 3-gate defense:

  • Gate 1 (Recruitment): Triple opt-in email domain authentication and LinkedIn profile matching.
  • Gate 2 (Router Defense): Digital fingerprinting, residential IP verification, and honeypot question traps.
  • Gate 3 (In-Survey): Median LOI speeder gating (<40%), straightline variance analysis, and NLP open-end validation.

4. Strategic Decision & Empirical Findings

Strategic Impact: Streamlined automated clinical site reconciliation protocols reducing submission lag by 40%. All data deliveries included raw CSV tables, cross-tabulated SPSS (.sav) outputs, and audit logs certified under ISO 20252:2019.

Fieldwork Telemetry

Verified Sample Yield
N=400 Pharmacovigilance Officers & Clinical Investigators
Fieldwork Turnaround
10 Business Days
Authentication Gating
GCP/ICH Certified Investigators
Quality Compliance
ISO 20252:2019 · EphMRA Certified

Commission Similar Fieldwork

Submit your target audience screening criteria to receive verified feasibility indices and pricing within 90 minutes.

Submit Research RFP Feasibility Tool

Related Dossiers